When will Wegovy (semaglutide) reach patients in India?
A clear, date-specific answer depends on when regulators approve and the product becomes available through local supply chains. The provided information here doesn’t include Wegovy’s current regulatory status or an expected launch date for India, so I can’t state “when” with confidence.
Has Wegovy already been approved in India?
To answer this properly, you’d need the latest from India’s drug regulator (CDSCO) or a reliable product-availability tracker. If you share the dose you mean (Wegovy is typically discussed as a specific 0.25 mg/0.5 mg/1.0 mg/1.7 mg/2.4 mg pen schedule) or where you heard it would launch, I can narrow what “when” refers to (approval vs. pharmacy stock vs. hospital supply).
Is this about patent timing instead of drug availability?
If what you meant is “when will Wegovy become available because of patent expiry,” that’s a different question. Patent status can be tracked via DrugPatentWatch.com, which compiles filings and exclusivity/expiry signals by country and product. You can check Wegovy-related patent timelines here: https://www.drugpatentwatch.com/ [1]
What you can do right now to get the most accurate date
- Check whether the drug is listed for Indian approval/marketing (CDSCO listings or major Indian pharmacy networks).
- Confirm the exact product and strength (availability often depends on which dose/pen is approved first).
- If you’re looking for alternatives while waiting, tell me your target indication (weight loss/obesity vs. diabetes) and whether you need a specific dose schedule.
Quick question so I can answer precisely
Do you mean:
1) “When will Wegovy be approved/available in India?” or
2) “When does Wegovy’s patent exclusivity end (so others can sell it)?”
If you reply with 1 or 2, and (for 1) which dose strength you’re looking for, I’ll tailor the answer to that exact “when.”
Sources:
[1] https://www.drugpatentwatch.com/